Role of incretin based therapies in the treatment of diabetic kidney disease
Diabetic kidney disease (DKD), a serious microvascular complication of diabetes mellitus is a leading cause of end-stage renal disease and is associated with an increased risk of cardiovascular morbidity and mortality. Despite advancements in blood glucose and blood pressure (BP) control, ~20% to 40...
Saved in:
| Main Authors: | Paola Fioretto, Andrea Frascati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2018-11-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/9845 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01) -
Incretin-Based Therapies and Cancer: What’s New?
by: Sanja Medenica, et al.
Published: (2025-04-01) -
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014-03-01) -
The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
by: Jakub Waszczyński, et al.
Published: (2025-01-01) -
Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
by: Yury Ivanovich Suntsov
Published: (2012-03-01)